European Pharmaceutical Review

Having trouble reading this email? View the web version here \| Forward this email to a colleague

MycoSEQ® Mycoplasma Detection System

Mycoplasmas are potential contaminants in mammalian cell culture manufacturing. To ensure product quality, regulatory agencies recommend that all products produced in cell culture be tested for the presence of Mycoplasma. However, detecting these contaminants is difficult, sometimes impossible, when using traditional microbiological techniques.

The current Mycoplasma test is a 28-day culture test. In 2007, the European Pharmacopeia accepted nucleic acid tests, such as real-time PCR, as an alternative method for traditional Mycoplasma detection after validation.

Company Directory

Premium & Premium+ listings:

- ABB Analytical Measurements
- Almac
- BD Diagnostics
- Bio-Optronics, Inc.
- bioMérieux
- BioTek Instruments, Inc.
- BMG LABTECH GmbH
- Bruker Daltonik GmbH
- CAMO Software AS
- CI Precision
- Cisbio Bioassays
- Colder Products Company
- DCA Design International
- DiscoveRx Corporation
- Expo Technologies, LLC.
- Freeman Technology
- GE Analytical Instruments
- HACH LANGE GMBH
- HORIBA Scientific
- Hudson Robotics, Inc.
- IDBS
- Natoli Engineering Company, Inc.
- Peter Huber Kältemaschinenbau GmbH
- Randox Pharma Services
- Rapid Micro Biosystems
- Sapient Discovery
- Smithers Viscient
- Synbiosis
- Syngene
- TOPRA
- Watson-Marlow Pumps Group

Conferences, events & exhibitions

High Content Analysis 2012
10 - 13 January 2012, San Francisco, CA, USA

IFPAC 2012
22 - 25 January 2012, Baltimore, USA

SLAS 2012
4 - 8 February 2012, San Diego, CA, USA

Drug Discovery for Neurodegeneration
12 - 14 February 2012, New York, USA

4th International Conference on Drug Discovery and Therapy
12 - 15 February 2012, Dubai, UAE

9th Annual PAT and Quality by Design
20 - 22 February 2012, London, UK

7th Annual Biomarkers Congress
22 - 23 February 2012, Manchester, UK

BIA Research & Development Conference
28 February 2012, London, UK

GDDIF 2012
7 - 8 March 2012, Budapest, Hungary

Teva announces management succession Phillip Frost, MD, Chairman of the Board of Directors of Teva Pharmaceutical Industries Ltd. has announced that Shlomo Yanai, President and CEO of Teva, plans to retire from the company effective May 2012, and that Dr. Jeremy Levin, a former senior executive at Bristol-Myers Squibb, will succeed him at that time. Read the full story >>

More pharmaceutical & life science news

		Tivozanib demonstrated superiority over sorafenib in patients with advanced renal cell cancer in Phase 3 TIVO-1 trial Tivozanib has demonstrated superiority over sorafenib...

		Advanced magnetic resonance imaging technology suggests axonal repair in MS patients treated with COPAXONE® Study findings published in Frontiers in Bioscience...

		Onfi™ (clobazam) tablets now available in the US at retail pharmacies Lundbeck announced that Onfi tablets are now available for prescribing in the United States...

		Pfizer receives FDA approval to extend use of Prevnar 13® First pneumococcal conjugate vaccine for adults 50+ has potential to help address high incidence of pneumococcal pneumonia...

		FDA to review potential new use of XGEVA® (Denosumab) at ODAC meeting FDA has invited Amgen to participate in a meeting of the ODAC on Feb. 8, 2012 to discuss the sBLA for XGEVA® (denosumab)...

		Janssen Research & Development submits application to U.S. FDA for XARELTO® (rivaroxaban) to reduce secondary cardiovascular events in patients with ACS Janssen Research & Development, LLC (JRD) have announced that it has submitted a sNDA to the FDA seeking approval for the use of XARELTO® (rivaroxaban)...

		ICON announces Dr. Anthony Murphy to retire from Board of Directors ICON plc., has announced the retirement of Non-Executive Director, Dr. Anthony Murphy to become effective on 31st December 2011...

Featured supplier news

		Syrris chemical reactors – good under pressure Syrris, offers a range of reactors designed specifically for applications requiring elevated pressures...

		B&W Tek announces PolymerIQTM for quantification of polymers in partnership with Gnosys Global Ltd B&W Tek, Inc., announced its newest strategic partnership with Gnosys Global, Ltd...

		Syrris releases new batch chemistry reactors catalogue Syrris is pleased to announce the release of its new batch chemistry reactors catalogue...

		Tecan launches Infinite® M1000 PRO with AlphaScreen® and AlphaLISA® technology Infinite M1000 PRO is Tecan’s latest generation high-end multimode microplate reader...


This email was sent to [email address suppressed] Click here if you no longer wish to receive the European Pharmaceutical Review email newsletter This email was sent by: European Pharmaceutical Review, Russell Publishing Ltd, Court Lodge, Hogtrough Hill, Brasted, Kent, TN16 1NU, United Kingdom

MycoSEQ® Mycoplasma Detection System

Company Directory

Conferences, events & exhibitions

Teva announces management succession

More pharmaceutical & life science news

Featured supplier news